Vaccine
2 April 2026
Attitudes toward vaccines and antivirals for viral respiratory infections in a survey of US adults with chronic health conditions
PharmaTimes
29 January 2026
ENA Respiratory begins dosing in phase 2 study of INNA-051 nasal sprayBioCentury
5 January 2026
ENA Respiratory: Boosting prophylactic immunity with a pan-viral nasal sprayFinancial Review
27 October 2025
Bill Gates, Brandon Capital back Aussie flu-fighting start-upView article [Behind paywall]
PharmaTimes
22 October 2025
ENA Respiratory secures US$22.4m to advance nasal spray therapyThe Pharma Letter
18 December 2024
Airing in journal a further step forward for ENA RespiratoryBiotechDispatch
10 September 2024
ENA Respiratory secures extension of US funding for novel prophylactic antiviralForbes
12 September 2023
It beat the Covid virus, so why did this Aussie startup get $12m from the US military to start over?Respiratory Therapy
1 May 2022
Antiviral Nasal Spray Being Developed by ENA Respiratory, COPD FoundationFierce Pharma
28 February 2022
COPD Foundation links arms with ENA on antiviral nasal spray ahead of phase 2 trials in COVID-19, fluFierce Biotech
13 February 2022
ENA slices data to claim flu success in phase 2 and nasal spray’s wide-ranging potentialPharmafile
18 December 2020
ENA Respiratory’s nasal spray reduces COVID-19 replication by 96%BioWorld
29 September 2020
ENA Respiratory launches with AU$11.7M series A as it heads toward clinic with COVID-19 nasal sprayView article [behind a paywall]
The Standard
28 September 2020
Weekly nasal spray could offer protection from Covid-19, research finds
